Generate a tailored SOP for Dr. Robin Choudhury. Improve your application with a focused, well-structured draft.
Robin Choudhury qualified in medicine from the University of Oxford, followed by postgraduate training in London at the Royal Brompton and Hammersmith hospitals as well as the Mount Sinai School of Medicine in New York. He is a Professor of Cardiovascular Medicine at the University of Oxford and an Honorary Consultant Cardiologist at John Radcliffe Hospital. His research focuses on understanding inflammatory processes, particularly in relation to atherosclerosis and acute myocardial infarction. He serves as a co-Principal Investigator for the NovoNordisk Foundation-supported MeRIAD consortium, which investigates metabolite-related inflammation-related diseases, and holds the position of Chief Investigator for the ZEUS clinical trial assessing Ziltivekimab. Choudhury's clinical practice centers on the management of coronary artery disease, with particular expertise in cardiovascular risk assessment and optimization, particularly in assessing interactions of cholesterol, diabetes, and genetic risk factors in relation to inflammation. His laboratory conducts translational science aimed at understanding the roles of innate immune cells in tissue homeostasis and injury repair, with a keen interest in hyperglycemia-induced trained immunity and the behavior of immune cells during acute myocardial infarction and myocardial regeneration versus repair.
Department of Politics and International Relations - Higher Level English requirement.